Skip to main content
. 2017 Nov;10(2):144–153. doi: 10.15283/ijsc17043

Fig. 4.

Fig. 4

α-SMA-Immunohistochemistry of skin wound sections: (A) Group-I, 3 days of treatment disclosing mild expression of α-SMA. Immunoperoxidase×200; (B) Group-II, 3 days of treatment showing mild immunoreactivity. Immunoperoxidase×400; (C) Group-I, 7 days of treatment revealing moderate positive expression of α-SMA. Immunoperoxidase×200; (D) Group-II, 7 days of treatment disclosing, marked positive expression of α-SMA. Immunoperoxidase×200; (E) Group-I at 14 days of treatment showing moderate immunoreactivity. Immunoperoxidase×400; (F) Group-II, 14 days of treatment revealing moderate positive expression of α-SMA. Immunoperoxidase×200.